These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesic™ M) in the treatment of migraine. Cady RK; Goldstein J; Nett R; Mitchell R; Beach ME; Browning R Headache; 2011; 51(7):1078-86. PubMed ID: 21631494 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of high-flow oxygen therapy in all types of headache: a prospective, randomized, placebo-controlled trial. Ozkurt B; Cinar O; Cevik E; Acar AY; Arslan D; Eyi EY; Jay L; Yamanel L; Madsen T Am J Emerg Med; 2012 Nov; 30(9):1760-4. PubMed ID: 22560101 [TBL] [Abstract][Full Text] [Related]
10. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets. Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814 [TBL] [Abstract][Full Text] [Related]
11. A review of the current and potential oxygen delivery systems and techniques utilized in cluster headache attacks. Oude Nijhuis JC; Haane DY; Koehler PJ Cephalalgia; 2016 Sep; 36(10):970-9. PubMed ID: 26566938 [TBL] [Abstract][Full Text] [Related]
12. Non-Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 Study. Silberstein SD; Mechtler LL; Kudrow DB; Calhoun AH; McClure C; Saper JR; Liebler EJ; Rubenstein Engel E; Tepper SJ; Headache; 2016 Sep; 56(8):1317-32. PubMed ID: 27593728 [TBL] [Abstract][Full Text] [Related]
13. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS). Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ; Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101 [TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues. Cady R; Schreiber C Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501 [TBL] [Abstract][Full Text] [Related]
15. Oxygen inhibits neuronal activation in the trigeminocervical complex after stimulation of trigeminal autonomic reflex, but not during direct dural activation of trigeminal afferents. Akerman S; Holland PR; Lasalandra MP; Goadsby PJ Headache; 2009 Sep; 49(8):1131-43. PubMed ID: 19719541 [TBL] [Abstract][Full Text] [Related]